Professor Andrew Westwell



Prosiectau fel Prif Ymchwiliwr
null null 1 o 3 null null

Synthetic routes of 18F labelled gemicitabine and related 2"-fluoronucleotides - Cyllidwr:Cancer Research Wales (01.10.2011 - 30.09.2014)
Discovery of novel site-specific FAK inhibitors for potential treatment of metastatic breast cancer - Cyllidwr:Welsh Government, - Cyllidwr:HEFCW (01.01.2015 - 31.12.2015)
Cancer drug discovery: Targeting protein - protein interactions - Cyllidwr:Universiti Putra Malaysia (01.10.2007 - 01.10.2010)
Inhibitors of aB-crystallin (CRYAB) for the treatment of triple-negative breast cancer - Cyllidwr:Cancer Research Wales (01.09.2014 - 31.12.2016)
Advancing analogues of a novel cFlip inhibitor which sensitises breast cancer cells and stem cells to TRAIL - Cyllidwr:Welsh Government, - Cyllidwr:HEFCW (01.10.2015 - 30.09.2016)


Prosiectau fel Cyd-Ymchwiliwr
null null 1 o 5 null null

Sensitizing to radiotherapy: Pre clinical evaluation of a novel indication for adjuvant Bcl3i - Cyllidwr:Welsh Government, - Cyllidwr:HEFCW (01.10.2015 - 31.12.2016)
The identification and selection of candidate lead compounds against BCL3 - Cyllidwr:BioVitas Capital Ltd, - Cyllidwr:Tiziana Pharma Ltd (01.11.2013 - 13.10.2017)

Diweddarwyd y tro diwethaf ar 2020-29-03 am 04:05